Aptose Biosciences
Why Robinhood?
You can watch APTOF and buy or sell other stocks, ETFs, and their options commission-free!About APTOF
Aptose Biosciences, Inc. is a clinical-stage oncology company, which engages in the discovery, research, and development of anti-cancer therapies. Its product pipeline includes APTO-253, a small molecule that induces expression of the Kruppel-Like Factor 4 genes; and CG-806 a non-covalent small molecule therapeutic agent.
APTOF Key Statistics
Stock Snapshot
With a market cap of 4.31M, Aptose Biosciences(APTOF) trades at $1.69. The stock has a price-to-earnings ratio of -0.16.
On 2026-08-24, Aptose Biosciences(APTOF) stock opened at —, reached a high of —, and a low of —.
The Aptose Biosciences(APTOF)'s current trading volume is 0, compared to an average daily volume of 5.09K.
During the past year, Aptose Biosciences(APTOF) stock moved between $0.89 at its lowest and $1.85 at its peak.
During the past year, Aptose Biosciences(APTOF) stock moved between $0.89 at its lowest and $1.85 at its peak.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.